Salvianolic acid B inhibits atherogenesis of vascular cells through induction of Nrf2-dependent Heme oxygenase-1

Current Medicinal Chemistry

Volumn 21, Issue 26, 2014, Pages 3095-3106

  Lee, Hyun Jung ^a,b   Seo, Mi Ran ^b   Lee, Eun Jig ^a  

^a Yonsei University College of Medicine   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

Author keywords

HO 1; HUVEC; Inflammation; Nrf2; Proliferation; Salvianolic acid B; VSMC

Indexed keywords

HEME OXYGENASE 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; PLATELET DERIVED GROWTH FACTOR; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; SALVIANOLIC ACID B; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR NRF2; TUMOR NECROSIS FACTOR ALPHA; BENZOFURAN DERIVATIVE; NFE2L2 PROTEIN, RAT;

ANIMAL CELL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; ATHEROGENESIS; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVATION; EX VIVO STUDY; HYPERPLASIA; INFLAMMATION; MOUSE; NEOINTIMA; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; UMBILICAL VEIN ENDOTHELIAL CELL; VASCULAR SMOOTH MUSCLE; ANIMAL; CELL CULTURE; DRUG EFFECTS; HUMAN; METABOLISM; SMOOTH MUSCLE FIBER; SPRAGUE DAWLEY RAT; TISSUE CULTURE TECHNIQUE;

ANIMALS; BENZOFURANS; CELLS, CULTURED; HEME OXYGENASE-1; HUMANS; MYOCYTES, SMOOTH MUSCLE; NF-E2-RELATED FACTOR 2; RATS, SPRAGUE-DAWLEY; TISSUE CULTURE TECHNIQUES;

EID: 84906086821     PISSN: 09298673     EISSN: 1875533X     Source Type: Journal    
DOI: 10.2174/0929867321666140601195940     Document Type: Article

References (31)

1. Cheng, T.O. Cardiovascular effects of Danshen. Int. J. Cardiol., 2007, 121(1), 9-22.
2. Zhou, L.; Zuo, Z.; Chow, M.S. Danshen: an overview of its chemistry, pharmacology, pharmacokinetics, and clinical use. J. Clin. Pharmacol., 2005, 45(12), 1345-1359.
3. Jiang, R.W.; Lau, K.M.; Hon, P.M.; Mak, T.C.; Woo, K.S.; Fung, K.P. Chemistry and biological activities of caffeic acid derivatives from Salvia miltiorrhiza. Curr. Med. Chem., 2005, 12(2), 237-246.
4. Wu, Y.J.; Hong, C.Y.; Lin, S.J.; Wu, P.; Shiao, M.S. Increase of vitamin E content in LDL and reduction of atherosclerosis in cholesterol-fed rabbits by a water-soluble antioxidant-rich fraction of Salvia miltiorrhiza. Arterioscler. Thromb. Vasc. Biol., 1998, 18(3), 481-486.
5. Ross, R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature, 1993, 362(6423), 801-809.
6. Madamanchi, N.R.; Vendrov, A.; Runge, M.S. Oxidative stress and vascular disease. Arterioscler. Thromb. Vasc. Biol., 2005, 25(1), 29-38.
7. Clempus, R.E.; Griendling, K. Reactive oxygen species signaling in vascular smooth muscle cells. Cardiovasc. Res., 2006, 71(2), 216-225.
8. Tulis, D.A.; Durante, W.; Liu, X.; Evans, A.J.; Peyton, K.J.; Schafer, A.I. Adenovirus-mediated heme oxygenase-1 gene delivery inhibits injury-induced vascular neointima formation. Circulation, 2001, 104(22), 2710-2715.
9. Juan, S.H.; Lee, T.S.; Tseng, K.W.; Liou, J.Y.; Shyue, S.K.; Wu, K.K.; Chau, L.Y. Adenovirus-mediated heme oxygenase-1 gene transfer inhibits the development of atherosclerosis in apolipoprotein E-deficient mice. Circulation, 2001, 104(13), 1519-1525.
10. Yet, S.F.; Layne, M.D.; Liu, X.; Chen, Y.H.; Ith, B.; Sibinga, N.E.; Perrella, M.A. Absence of heme oxygenase-1 exacerbates atherosclerotic lesion formation and vascular remodeling. FASEB J., 2003, 17(12), 1759-1761.
11. Motohashi, H.; Yamamoto, M. Nrf2-Keap1 defines a physiologically important stress response mechanism. Trends Mol. Med., 2004, 10(11), 549-557.
12. Kensler, T.W.; Wakabayashi, N.; Biswal, S. Cell survival responses to environmental stresses via the Keap1-Nrf2-ARE pathway. Annu. Rev. Pharmacol. Toxicol., 2007, 47, 89-116.
13. Zhao, G.R.; Zhang, H.M.; Ye, T.X.; Xiang, Z.J.; Yuan, Y.J.; Guo, Z.X.; Zhao, L.B. Characterization of the radical scavenging and antioxidant activities of danshensu and salvianolic acid B. Food Chem. Toxicol., 2008, 46(1), 73-81.
14. Lee, S.; Lim, H.J.; Park, H.Y.; Lee, K.S.; Park, J.H.; Jang, Y. Berberine inhibits rat vascular smooth muscle cell proliferation and migration in vitro and improves neointima formation after balloon injury in vivo. Berberine improves neointima formation in a rat model. Atherosclerosis, 2006, 186(1), 29-37.
15. Cho, Y.H.; Ku, C.R.; Hong, Z.Y.; Heo, J.H.; Kim, E.H.; Choi, D.H.; Kim, D.; Kim, A.J.; Lee, C.S.; Jung, M.; Lee, H.C.; Seo, M.; Lee, E.J. Therapeutic effects of water soluble danshen extracts on atherosclerosis. Evid. Based Complement Alternat. Med., 2013, 623639.
16. Lin, S.J.; Lee, I.T.; Chen, Y.H.; Lin, F.Y.; Sheu, L.M.; Ku, H.H.; Shiao, M.S.; Chen, J.W.; Chen, Y.L. Salvianolic acid B attenuates MMP-2 and MMP-9 expression in vivo in apolipoprotein-Edeficient mouse aorta and in vitro in LPS-treated human aortic smooth muscle cells. J. Cell. Biochem., 2007, 100(2), 372-384.
17. Y, J.; M, Z.; HJ, K.; S, K.; MJ, U.; C, P.; G, R.d.; SS, K.; S, R.; SW, R.; KC, C.; HT, C.-Salvianolic acid B exerts vasoprotective effects through the modulation of heme oxygenase-1 and arginase activities. J. Pharmacol. Exp. Ther., 2012, 341(3), 850-858.
18. Sriram, V.; Patterson, C. Cell cycle in vasculoproliferative diseases: potential interventions and routes of delivery. Circulation, 2001, 103(19), 2414-2419.
19. Jackson, C.L.; Raines, E.W.; Ross, R.; Reidy, M.A. Role of endogenous platelet-derived growth factor in arterial smooth muscle cell migration after balloon catheter injury. Arterioscler. Thromb., 1993, 13(8), 1218-1226.
20. Lewis, C.D.; Olson, N.E.; Raines, E.W.; Reidy, M.A.; Jackson, C.L. Modulation of smooth muscle proliferation in rat carotid artery by platelet-derived mediators and fibroblast growth factor-2. Platelets, 2001, 12(6), 352-358.
21. Sundaresan, M.; Yu, Z.X.; Ferrans, V.J.; Irani, K.; Finkel, T. Requirement for generation of H2O2 for platelet-derived growth factor signal transduction. Science, 1995, 270(5234), 296-299.
22. Kreuzer, J.; Viedt, C.; Brandes, R.P.; Seeger, F.; Rosenkranz, A.S.; Sauer, H.; Babich, A.; NÃ-rnberg, B.; Kather, H.; Krieger Brauer, H.I. Platelet-derived growth factor activates production of reactive oxygen species by NAD(P)H oxidase in smooth muscle cells through Gi1,2. FASEB J., 2003, 17(1), 38-40.
23. Higaki, M.; Shimokado, K. Phosphatidylinositol 3-kinase is required for growth factor-induced amino acid uptake by vascular smooth muscle cells. Arterioscler. Thromb. Vasc. Biol., 1999, 19(9), 2127-2132.
24. Elahi, M.M.; Kong, Y.X.; Matata, B.M. Oxidative stress as a mediator of cardiovascular disease. Oxid. Med. Cell Longev., 2009, 2(5), 259-269.
25. Dai, G.; Vaughn, S.; Zhang, Y.; Wang, E.T.; Garcia-Cardena, G.; Gimbrone, M.A., Jr. Biomechanical forces in atherosclerosisresistant vascular regions regulate endothelial redox balance via phosphoinositol 3-kinase/Akt-dependent activation of Nrf2. Circ. Res., 2007, 101(7), 723-733.
26. Ashino, T.; Yamamoto, M.; Yoshida, T.; Numazawa, S. Redox-Sensitive Transcription Factor Nrf2 Regulates Vascular Smooth Muscle Cell Migration and Neointimal Hyperplasia. Arterioscler. Thromb. Vasc. Biol., 2013, 33(4), 760-768.
27. Kumar, S.; Sharma, A.; Madan, B.; Singhal, V.; Ghosh, B. Isoliquiritigenin inhibits IkappaB kinase activity and ROS generation to block TNF-alpha induced expression of cell adhesion molecules on human endothelial cells. Biochem. Pharmacol., 2007, 73(10), 1602-1612.
28. Pan, L.L.; Liu, X.H.; Gong, Q.H.; Wu, D.; Zhu, Y.Z. Hydrogen sulfide attenuated tumor necrosis factor-alpha-induced inflammatory signaling and dysfunction in vascular endothelial cells. PLoS ONE, 2011, 6(5), e19766.
29. Gloire, G.; Legrand-Poels, S.; Piette, J. NF-kappaB activation by reactive oxygen species: fifteen years later. Biochem. Pharmacol., 2006, 72(11), 1493-1505.
30. Li, W.; Khor, T.O.; Xu, C.; Shen, G.; Jeong, W.S.; Yu, S.; Kong, A.N. Activation of Nrf2-antioxidant signaling attenuates NFkappaB-inflammatory response and elicits apoptosis. Biochem. Pharmacol., 2008, 76(11), 1485-1489.
31. Wu, Y.T.; Chen, Y.F.; Hsieh, Y.J.; Jaw, I.; Shiao, M.S.; Tsai, T.H. Bioavailability of salvianolic acid B in conscious and freely moving rats. Int. J. Pharm., 2006, 326(1-2), 25-31.